Kurome Therapeutics closes $15 million Series A financing
Funding to develop targeted kinase inhibitors for treatment of hematopoietic cancers Kurome Therapeutics, a preclinical stage company dedicated to developing ...
Funding to develop targeted kinase inhibitors for treatment of hematopoietic cancers Kurome Therapeutics, a preclinical stage company dedicated to developing ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.